27 April 2025
: Case report 
From Erysipelas to Epiglottitis: Managing Complications in Invasive Group A Streptococcal Infection
Unusual clinical course
Shuhei Matsumoto ABCDEF 1, Takuya Masuda D 2, Nobuyoshi Minemura ABCDEF 2*, Hiroyoshi Nakajima DE 2, Keita Tatsuno
DE 3
DOI: 10.12659/AJCR.947291
Am J Case Rep 2025; 26:e947291
Table 2. Sensitivity profile of isolated S. pyogenes.
| Sputum | Blood | |
|---|---|---|
| Vancomycin | S 0.5 | S 0.5 |
| Cefepime | S ≤4 | S ≤4 |
| Penicillin G | S ≤0.03 | S ≤0.03 |
| Ampicillin | S ≤0.06 | S ≤0.06 |
| Ceftriaxone | S ≤0.12 | S ≤0.12 |
| Cefpirome | S ≤0.5 | S ≤0.5 |
| Ceftizoxime | S ≤0.12 | S ≤0.12 |
| Cefotaxime | S ≤0.12 | S ≤0.12 |
| Meropenem | S ≤0.12 | S ≤0.12 |
| Erythromycin | S ≤0.12 | S ≤0.12 |
| Clindamycin | S ≤0.12 | S ≤0.12 |
| Azithromycin | S ≤0.25 | S ≤0.25 |
| Minocycline | S ≤0.5 | S 1 |
| Levofloxacin | S 0.5 | S 0.5 |